福贝生物医药科技

ForBio Therapeutics is a clinical-stage biotechnology company dedicated to the discovery and development of first-in-class treatments for neurodegenerative diseases. Founded by world-renowned neuroscientist Dr. Lu Bai, the company focuses on addressing high unmet medical needs in conditions such as Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia (FTD), and Alzheimer's disease. ForBio leverages a proprietary platform that targets neurotrophic factor signaling and protein homeostasis to develop both small molecule and gene therapy candidates. With operations in China and the United States, the company is advancing a robust pipeline through global clinical trials. Its lead programs aim to provide disease-modifying solutions by restoring neuronal health and function.